Tesi’s portfolio company: Hedera DX SA - tesi.fi

Suomeksi

Search for

For companies
For investors
Investments
- Investments
- Companies
- Funds
- Cases
Team
News
Market data
Sustainability
About Tesi

HomeCompaniesHedera DX SA

www.hederadx.com

Portfolio
Scaleup & Growth Investments

Industry
Health & Life Science

Manager
Joni Karsikas

Investment Year
2025

Hedera is a Finnish-Swiss health tech scale-up that has developed a new liquid biopsy test for cancer diagnostics, and whose business model also includes leveraging data for pharmaceutical clients’ research.

News
27.5.2025

Scale-up company Hedera secures EUR 15 million in growth funding for new cancer diagnostics solution

Scale-up company Hedera secures EUR 15 million in growth funding for new cancer diagnostics solution

Subscribe

* indicates required

Email Address *

First Name

Last Name

How often would you like to hear from us? *

Daily, if there is new content
Once a week
Once a month

Marketing Permissions *

Accept

By accepting this form, you give Tesi and the partners who produce its newsletter permission to process your information with the newsletters. You can unsubscribe at any time by clicking the link in the footer of our emails or by contacting info@tesi.fi For information about our privacy practices, please visit our website https://www.tesi.fi/en/privacy-policy/.

Grow Together.

Tesi (Finnish Industry Investment Ltd)
Porkkalankatu 1, 00180 Helsinki